Habermann, Thomas M.

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Chapuy, B., Stewart, C., Dunford, A. J., Kim, J., Kamburov, A., Redd, R. A., Lawrence, M. S., Roemer, M. G. M., Li, A. J., Ziepert, M., et al. (2018) · Nature Medicine

Lymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and Treatment

Cited by 1,941

Association of Perceived Medical Errors With Resident Distress and Empathy: A Prospective Longitudinal Study

West, C. P., Huschka, M. M., Novotny, P. J., Sloan, J. A., Kolars, J. C., Habermann, T. M., & Shanafelt, T. D. (2006) · JAMA

Healthcare professionals’ stress and burnoutPatient Safety and Medication Errors

Cited by 1,454

The well-being of physicians

Shanafelt, T. D., Sloan, J. A., & Habermann, T. M. (2003) · The American Journal of Medicine

Healthcare professionals’ stress and burnoutOccupational Health and Burnout

Cited by 813

Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement

Al-Adra, D. P., Hammel, L., Roberts, J., Woodle, E. S., Levine, D., Mandelbrot, D., Verna, E., Locke, J., D’Cunha, J., Farr, M., et al. (2021) · American Journal of Transplantation

Transplantation: Methods and OutcomesOrgan and Tissue Transplantation Research

Cited by 163

Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio

Porrata, L. F., Ristow, K., Habermann, T., Inwards, D. J., Micallef, I. N., & Markovic, S. N. (2010) · American Journal of Hematology

Inflammatory Biomarkers in Disease PrognosisLymphoma Diagnosis and Treatment

Cited by 124

Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells

Shenoy, N., Bhagat, T., Nieves, E., Stenson, M., Lawson, J., Choudhary, G. S., Habermann, T., Nowakowski, G., Singh, R., Wu, X., et al. (2017) · Blood Cancer Journal

Epigenetics and DNA MethylationVitamin C and Antioxidants Research

Cited by 111

Localization of eosinophil granule major basic protein in human basophils.

Ackerman, S. J., Kephart, G. M., Habermann, T. M., Greipp, P. R., & Gleich, G. J. (1983) · The Journal of experimental medicine

Mast cells and histamineAsthma and respiratory diseases

Cited by 99

Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement

Al-Adra, D. P., Hammel, L., Roberts, J., Woodle, E. S., Levine, D., Mandelbrot, D., Verna, E., Locke, J., D’Cunha, J., Farr, M., et al. (2021) · American Journal of Transplantation

Cutaneous Melanoma Detection and ManagementTransplantation: Methods and Outcomes

Cited by 87

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

Machiela, M. J., Lan, Q., Slager, S. L., Vermeulen, R. C. H., Teras, L. R., Camp, N. J., Cerhan, J. R., Spinelli, J. J., Wang, S. S., Nieters, A., et al. (2016) · Human Molecular Genetics

Telomeres, Telomerase, and SenescenceGenetic Associations and Epidemiology

Cited by 58

A first-in-human phase I study of OPB-111077, a small-molecule STAT3 and oxidative phosphorylation inhibitor, in patients with advanced cancers

Tolcher, A., Flaherty, K., Shapiro, G. I., Berlin, J., Witzig, T., Habermann, T., Bullock, A., Rock, E., Elekes, A., Lin, C., et al. (2018) · The Oncologist

Cytokine Signaling Pathways and InteractionsLung Cancer Treatments and Mutations

Cited by 57

Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study

Charbonneau, B., Maurer, M. J., Ansell, S. M., Slager, S. L., Fredericksen, Z. S., Ziesmer, S. C., Macon, W. R., Habermann, T. M., Witzig, T. E., Link, B. K., et al. (2012) · Cytokine

Lymphoma Diagnosis and TreatmentViral-associated cancers and disorders

Cited by 55